Sentynl Therapeutics, Inc.

Sentynl Therapeutics, Inc. company information, Employees & Contact Information

Explore related pages

Sentynl Therapeutics, Inc. email format Sentynl Therapeutics, Inc. management contacts

Related company profiles:

Sentynl Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases.

Company Details

Employees
24
Address
420 Stevens Avenue,
Phone
877-767-2656
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
sentynl.com
Keywords
jobs.
HQ
Solana Beach, California
Competitors
Maze Therapeutics, AZAFAROS B.V., MaaT Pharma, Metsera, Hoth Therapeutics, Inc, Ouro Medicines, IGM Biosciences, Inc., Aviceda Therapeutics, Verdiva Bio, Tenvie Therapeutics.
Looking for a particular Sentynl Therapeutics, Inc. employee's phone or email?

Sentynl Therapeutics, Inc. Questions

News

Sentynl Therapeutics updates on its NDA for CUTX-101 - PR Newswire

Sentynl Therapeutics updates on its NDA for CUTX-101 PR Newswire

Er-Kim Enters Commercialization Agreement with Sentynl - GlobeNewswire

Er-Kim Enters Commercialization Agreement with Sentynl GlobeNewswire

Sentynl Therapeutics Receives Great Place To Work® Certification - PR Newswire

Sentynl Therapeutics Receives Great Place To Work® Certification PR Newswire

Fortress, Sentynl Fail To Secure FDA Nod in Rare Pediatric Disease - BioSpace

Fortress, Sentynl Fail To Secure FDA Nod in Rare Pediatric Disease BioSpace

Fortress Biotech's Cyprium Therapeutics Receives Priority Review for CUTX-101 New Drug Application with Target Action Date of June 30, 2025 - Quiver Quantitative

Fortress Biotech's Cyprium Therapeutics Receives Priority Review for CUTX-101 New Drug Application with Target Action Date of June 30, 2025 Quiver Quantitative

FDA snubs Cyprium-Sentynl drug for rare pediatric disease due to manufacturing issues - Fierce Biotech

FDA snubs Cyprium-Sentynl drug for rare pediatric disease due to manufacturing issues Fierce Biotech

Sentynl acquires Eiger’s Zokinvy for progeria treatment - Pharmaceutical Technology

Sentynl acquires Eiger’s Zokinvy for progeria treatment Pharmaceutical Technology

USFDA accepts Sentynl's NDA for CUTX-101 - Business Standard

USFDA accepts Sentynl's NDA for CUTX-101 Business Standard

Sentynl Therapeutics Announces First Comprehensive Body of Clinical Evidence Supporting NULIBRY® (fosdenopterin) in Treating Molybdenum Cofactor Deficiency Type A Compared to Natural History - PR Newswire

Sentynl Therapeutics Announces First Comprehensive Body of Clinical Evidence Supporting NULIBRY® (fosdenopterin) in Treating Molybdenum Cofactor Deficiency Type A Compared to Natural History PR Newswire

BridgeBio Pharma and Sentynl Therapeutics Announce Asset - GlobeNewswire

BridgeBio Pharma and Sentynl Therapeutics Announce Asset GlobeNewswire

Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) Product Candidate for Treatment of Menkes Disease - PR Newswire

Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) Product Candidate for Treatment of Menkes Disease PR Newswire

Sentynl Therapeutics Announces Presentation at 2023 Pharmaceutical Compliance Congress - PR Newswire

Sentynl Therapeutics Announces Presentation at 2023 Pharmaceutical Compliance Congress PR Newswire

Cyprium Therapeutics, a Fortress Biotech Partner Company, - GlobeNewswire

Cyprium Therapeutics, a Fortress Biotech Partner Company, GlobeNewswire

Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals - PR Newswire

Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals PR Newswire

Sentynl Therapeutics Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease from Cyprium Therapeutics - PR Newswire

Sentynl Therapeutics Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease from Cyprium Therapeutics PR Newswire

Sentynl Therapeutics Recognizes Menkes Disease Awareness Month, Committed to the Development of Tests for Early Diagnosis of Patients with Menkes Disease - PR Newswire

Sentynl Therapeutics Recognizes Menkes Disease Awareness Month, Committed to the Development of Tests for Early Diagnosis of Patients with Menkes Disease PR Newswire

BridgeBio Pharma, Sentynl Therapeutics and Medison Pharma Announce Approval in Israel for NULIBRY® (fosdenopterin) for the Treatment of MoCD Type A - PR Newswire

BridgeBio Pharma, Sentynl Therapeutics and Medison Pharma Announce Approval in Israel for NULIBRY® (fosdenopterin) for the Treatment of MoCD Type A PR Newswire

BridgeBio Pharma and Sentynl Therapeutics Receive Positive CHMP Opinion for NULIBRY® (fosdenopterin) for the Treatment of MoCD Type A - PR Newswire

BridgeBio Pharma and Sentynl Therapeutics Receive Positive CHMP Opinion for NULIBRY® (fosdenopterin) for the Treatment of MoCD Type A PR Newswire

Zydus Cadila acquires US drugmaker Sentynl Therapeutics - VCCircle

Zydus Cadila acquires US drugmaker Sentynl Therapeutics VCCircle

Companies like Sentynl Therapeutics, Inc.

AZAFAROS B.V. logo - Similar company to Sentynl Therapeutics, Inc.

Azafaros B.V.

24
Maze Therapeutics logo - Similar company to Sentynl Therapeutics, Inc.

Maze Therapeutics

146
Aviceda Therapeutics logo - Similar company to Sentynl Therapeutics, Inc.

Aviceda Therapeutics

39
Tenvie Therapeutics logo - Similar company to Sentynl Therapeutics, Inc.

Tenvie Therapeutics

32
Verdiva Bio logo - Similar company to Sentynl Therapeutics, Inc.

Verdiva Bio

53
IGM Biosciences, Inc. logo - Similar company to Sentynl Therapeutics, Inc.

Igm Biosciences, Inc.

110
Hoth Therapeutics, Inc logo - Similar company to Sentynl Therapeutics, Inc.

Hoth Therapeutics, Inc

8
MaaT Pharma logo - Similar company to Sentynl Therapeutics, Inc.

Maat Pharma

85
Metsera logo - Similar company to Sentynl Therapeutics, Inc.

Metsera

101
Ouro Medicines logo - Similar company to Sentynl Therapeutics, Inc.

Ouro Medicines

16

Top Sentynl Therapeutics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant